当前位置: 首页 > 期刊 > 《中国医学创新》 > 2016年第10期
编号:12764364
复发性风湿症患者不良预后的影响因素的研究(4)
http://www.100md.com 2016年4月5日 中国医学创新 2016年第10期
     [7]梁东风,黄烽.复发性风湿症的诊断与治疗[J].中华全科医师杂志,2005,4(3):167-168.

    [8] Koskinen E,Hannonen P,Sokka T.Palindromic rheumatism:longterm outcomes of 60 patients diagnosed in 1967-84[J].J Rheumatol,2009,36(9):1873-1875.

    [9]梁东风,黄烽,张江林.复发性风湿症63例临床分析及1.5~3年随访结果[J].中华风湿病学杂志,2007,11(7):426-428.

    [10] Tamai M,Kawakami A,Iwamoto N,et al. Contribution of anti-CCP antibodies,proximal interphalangeal joint involvement, HLA-DRB1 shared epitope, and PADI4 as risk factors for the development of rheumatoid arthritis in palindromic rheumatism[J].Scand J Rheumatol,2010,39(4):287-291.

    [11] Emad Y,Anbar A,Abo-Elyoun I,et al.In palindromic rheumatism, hand joint involvement and positive anti-CCP antibodies predict RA development after 1 year of follow-up[J].Clin Rheumatol,2014,33(6):791-797.

    [12] SanmartíR,Cabrera-Villalba S,Gómez-Puerta J A,et al.Palindromic rheumatism with positive anticitrullinated peptide/protein antibodies is not synonymous with rheumatoid arthritis.A longterm followup study[J].J Rheumatol,2012,39(10):1929-1933.

    [13] Katz S J,Russell A S.Palindromic rheumatism:a are-rheumatoid arthritis state[J].J Rheumatol,2012,39(10):1912-1913.

    (收稿日期:2016-01-05) (本文编辑:刘蕾), http://www.100md.com(温艳芳 陈剑锋 廖湘平 肖华)
上一页1 2 3 4